Stay updated on SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial

Sign up to get notified when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No visible changes to the trial details content or layout were observed, indicating an internal update.
    Difference
    0.0%
    Check dated 2026-03-21T17:19:46.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3; the previous v3.4.2 tag was removed.
    Difference
    0.0%
    Check dated 2026-03-07T04:51:47.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing Revision: v3.4.1. No core study details or results appear to be altered.
    Difference
    0.0%
    Check dated 2026-02-13T12:37:18.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    A new Revision: v3.4.1 entry was added and the previous Revision: v3.4.0 entry was removed.
    Difference
    0.0%
    Check dated 2026-02-05T18:51:57.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the site, with no evident changes to the study details, eligibility criteria, locations, or outcomes. This appears to be a non-substantive update focused on the site's versioning. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:41:32.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    Locations section now lists participating states (Connecticut, Florida, Iowa, Massachusetts, Michigan, New York, North Carolina, Ohio, Oregon, Pennsylvania, Tennessee, Texas). The HHS Vulnerability Disclosure link was removed.
    Difference
    1%
    Check dated 2025-12-24T15:35:18.000Z thumbnail image

Stay in the know with updates to SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.